YZR Capital is a Munich-based venture capital firm investing in early-stage HealthTech startups across Europe. Founded by an exited telehealth founder, the firm provides capital and deep sector expertise to ambitious entrepreneurs tackling complex challenges in global healthcare.
60% of their portfolio is in Healthcare. Their most common stage is seed (73% of deals). Average disclosed round size is $8.5M (across 5 rounds with reported amounts).
Portfolio
15
Fund Size
$108M
Top Stage
Seed
Last 12 Mo
2
Team
RM
Reinhard Meier
Founding & Managing Partner
GG
Georg G.
HealthTech Investor
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
15 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Scripta Therapeutics | Seed | $12M | Nov 2025 |
 Doctor.one | Seed | — | Sep 2025 |
 DeepLife | Series A | — | Dec 2024 |
| Cclare&me | Seed | $3.7M | Aug 2024 |
| EEsper Bionics | Seed | — | Jun 2024 |
 Deepeye Medical | Seed | — | Nov 2023 |
 Scan.com | Series A | $12M | Jan 2023 |
 Scripta | Seed | $12M | — |
 OpenHealth Technologies | Seed | $3M | — |
 DaphOS | Seed | — | — |
 dehaze | Seed | — | — |
 HOLI | Seed | — | — |
| UUniva | Pre-Seed | — | — |
 Filu | Seed | — | — |
 caire | Pre-Seed | — | — |
Top Co-Investors
Apollo Health Ventures2 shared
Parkwalk Advisors2 shared
Oxford Science Enterprises2 shared
AlbionVC2 shared
Calm/Storm Ventures2 shared
Bayern Kapital2 shared
Antler1 shared
Intact Ventures1 shared
Headline1 shared
Beiersdorf Venture Capital1 shared
Plug and Play Tech Center1 shared
Oxford Capital1 shared
Simplyhealth Ventures1 shared
Forefront Venture Partners1 shared
Triple Point Ventures1 shared
Oxford University Innovation1 shared
Aquiline Capital Partners1 shared
Octopus Ventures1 shared
xDeck1 shared
Last updated: 9 September 2026